The estimated Net Worth of Joseph Todisco is at least $3.75 Million dollars as of 13 March 2024. Mr Todisco owns over 13,561 units of Amneal Pharmaceuticals Inc stock worth over $2,949,734 and over the last 5 years he sold AMRX stock worth over $6,150. In addition, he makes $790,123 as Exec. VP & Chief Commercial Officer of Specialty at Amneal Pharmaceuticals Inc.
Sign up
Mr MBA AMRX stock SEC Form 4 insiders trading
Mr has made over 15 trades of the Amneal Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 13,561 units of AMRX stock worth $50,718 on 13 March 2024.
The largest trade he's ever made was exercising 40,794 units of Amneal Pharmaceuticals Inc stock on 27 February 2021 worth over $341,038. On average, Mr trades about 10,902 units every 71 days since 2019. As of 13 March 2024 he still owns at least 352,839 units of Amneal Pharmaceuticals Inc stock.
You can see the complete history of Mr Todisco stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Joseph Todisco MBA biography
Joseph Todisco MBA is the Exec. VP & Chief Commercial Officer of Specialty at Amneal Pharmaceuticals Inc.
What is the salary of Mr MBA?
As the Exec. VP & Chief Commercial Officer of Specialty of Amneal Pharmaceuticals Inc, the total compensation of Mr MBA at Amneal Pharmaceuticals Inc is $790,123. There are 5 executives at Amneal Pharmaceuticals Inc getting paid more, with Andrew Boyer having the highest compensation of $3,113,080.
How old is Mr MBA?
Mr MBA is 45, he's been the Exec. VP & Chief Commercial Officer of Specialty of Amneal Pharmaceuticals Inc since . There are 19 older and 2 younger executives at Amneal Pharmaceuticals Inc. The oldest executive at Amneal Pharmaceuticals Inc is Shlomo Yanai, 67, who is the Independent Director.
What's Mr MBA's mailing address?
Joseph's mailing address filed with the SEC is C/O CORMEDIX INC., 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS, NJ, 07922.
Insiders trading at Amneal Pharmaceuticals Inc
Over the last 7 years, insiders at Amneal Pharmaceuticals Inc have traded over $867,197,480 worth of Amneal Pharmaceuticals Inc stock and bought 3,818,425 units worth $12,997,905 . The most active insiders traders include Gp A, Llcbonderman Davidcou..., Holdings, Llc Aphc und International Ltd Fosun. On average, Amneal Pharmaceuticals Inc executives and independent directors trade stock every 18 days with the average trade being worth of $3,857,739. The most recent stock trade was executed by Andrew S Boyer on 14 August 2024, trading 62,711 units of AMRX stock currently worth $491,654.
What does Amneal Pharmaceuticals Inc do?
an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients around the globe.
What does Amneal Pharmaceuticals Inc's logo look like?
Complete history of Mr Todisco stock trades at CorMedix Inc und Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals Inc executives and stock owners
Amneal Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Andrew Boyer,
Executive Vice President - Commercial Operations -
Chintu Patel R.Ph, R.Ph.,
Co-Founder, Co-CEO & Director -
Nikita Shah,
Chief Human Resource Officer, Senior Vice President -
Andrew S. Boyer,
Exec. VP & Chief Commercial Officer of Generics -
Anastasios G. Konidaris,
Exec. VP & CFO -
Joseph Todisco MBA,
Exec. VP & Chief Commercial Officer of Specialty -
Nikita Shah,
Exec. VP and Chief HR Officer & Strategic Planning Officer -
J. Kevin Buchi,
Independent Director -
Ted Nark,
Independent Director -
Emily Alva,
Independent Director -
Gautam Patel,
Director -
Chintu Patel,
Co-Chief Executive Officer, Co-Founder, Director -
Chirag Patel,
President, Co-Chief Executive Officer, Director -
Paul Meister,
Independent Chairman of the Board -
Shlomo Yanai,
Independent Director -
John Kiely,
Independent Director -
Jeffrey George,
Independent Director -
Chintu Patel R.Ph., R.Ph,
Co-Founder, Co-CEO & Director -
Chirag K. Patel,
Co-Founder, Co-CEO, Pres & Director -
Joseph Todisco,
Senior Vice President - Specialty Commercial -
Apurva Saraf,
Senior Vice President - Corporate Development -
Joseph Greer,
Senior Vice President - Global Quality Management -
Stephen Manzano,
Senior Vice President, General Counsel & Corporate Secretary -
Sanjay Jain,
President - India -
Anastasios Konidaris,
Chief Financial Officer, Senior Vice President -
Jason B. Daly Esq.,
Sr. VP, Chief Legal Officer & Corp. Sec. -
Dr. Nikunj Patel,
Head of Ops & Exec. VP of Amneal Pharmaceuticals (India) Pvt Ltd -
Sanjiv Patel,
Sr. VP of Operations -
Stephen J. Manzano,
Sr. VP, Gen. Counsel & Corp. Sec. -
Anthony DiMeo,
Sr. Director of Investor Relations -
Sheldon Hirt,
SVP, GC & Corp. Sec. -
Jean Selden Greene,
Director -
Holdings, Llc Aphc,
10% owner -
Robert L Burr,
Director -
Bryan M. Reasons,
CFO -
Robert A Stewart,
President and CEO -
Dharmendra Rama,
Director -
Janet S. Vergis,
Director -
Peter R Terreri,
Director -
Paul Bisaro,
Executive Chairman -
David A Buchen,
SVP, Chief Legal Officer -
Todd P. Branning,
SVP and CFO -
Pradeep Bhadauria,
SVP, Chief Scientific Officer -
International Ltd Fosun,
10% owner -
Gustavo Pesquin,
See Remarks -
Gp A, Llcbonderman Davidcou...,
-
Tasos Konidaris,
Executive Vice President & CFO -
Jason B. Daly,
SVP, Chief Legal Officer -
Deborah M. Autor,
Director -
Dipan Patel,
-
Tushar Bhikhubhai Patel,
10% owner